ERBB2 and breast cancer: The in vitro ability of the constructs to bind recombinant HER2 as well as human and mouse FcγRI were explored alongside with the in vivo performance in two different mouse models of HER2-expressing BT474 human breast cancer, one including athymic nude mice and the other humanized NSG (huNSG) mice.